MOLN Molecular
- 5.510
- -0.180-3.16%
- 5.550
- +0.040+0.73%
Molecular News
Molecular | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | F-3: Registration statement for specified transactions by certain foreign private issuers
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
No Data